Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence

J Antimicrob Chemother. 2019 Aug 1;74(8):2468-2470. doi: 10.1093/jac/dkz181.

Swiss HIV Cohort Study:
A Anagnostopoulos, M Battegay, E Bernasconi, J Böni, D L Braun, H C Bucher, A Calmy, M Cavassini, A Ciuffi, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, C A Fux, H F Günthard, D Haerry, B Hasse, H H Hirsch, M Hoffmann, I Hösli, M Huber, C R Kahlert, L Kaiser, O Keiser, T Klimkait, R D Kouyos, H Kovari, B Ledergerber, G Martinetti, B Martinez de Tejada, C Marzolini, K J Metzner, N Müller, D Nicca, P Paioni, G Pantaleo, M Perreau, A Rauch, C Rudin, A U Scherrer, P Schmid, R Speck, M Stöckle, P Tarr, A Trkola, P Vernazza, G Wandeler, R Weber, S Yerly

¹ Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
² Molecular Virology, Department Biomedicine Haus Petersplatz, University of Basel, Basel, Switzerland.
³ Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel and University of Basel, Basel, Switzerland.
⁴ Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁵ School of Pharmaceutical Sciences, University of Geneva and University of Lausanne, Geneva, Switzerland.
⁶ Clinical Research Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.
⁷ Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland.

No abstract available

Publication types